Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
about
Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin EAdd-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatinHypoxia-reoxygenation inhibits gap junctional communication in cultured human umbilical vein endothelial cells.Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.Study design and rationale of "Synergistic effect of combination therapy with cilostazol and ProbUcol on plaque stabilization and lesion REgression (SECURE)" study: a double-blind randomised controlled multicenter clinical trialVascular protectants for the treatment of atherosclerosis.Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.Preliminary Analysis of Modified Low-Density Lipoproteins in the Serum of Healthy and Obese Dogs and Cats.Antioxidants: the good, the bad and the uglyAGI-1067, a novel vascular protectant, anti-inflammatory drug and mild antiplatelet agent for treatment of atherosclerosis.Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice.The LDL modification hypothesis of atherogenesis: an update.Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.Low density lipoproteins and atherosclerosis-quantity or quality?Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein.Atherosclerosis as disease of redox-sensitive genes.Evaluations of toxicity of Turraeanthus africanus (Méliaceae) in mice.Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers.Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits.Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation.Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate.When does atherosclerosis become irreversible? Chronological change from an early to an advanced atherosclerotic lesion observed by angioscopy.Antioxidants in the Fight Against Atherosclerosis: Is This a Dead End?
P2860
Q28344980-6EF8E660-3617-4838-8E07-AF2D51BD0454Q28538633-F22BE41D-C161-464D-A244-4EE83CB7C19FQ30980397-537A6AEB-B717-4C9E-BDFE-A5482CB6311AQ33855324-409206E2-33D4-4456-935F-C504BE3228A9Q34552698-67D09651-AE85-4123-908D-D9DCB5032B9BQ35696297-A7366739-B916-4C1F-9AC9-135102C7D52EQ35765213-0571D28B-9868-4580-A041-E9B74A498F8EQ36055271-1B852E17-612B-4E2D-ABB2-1FAC3CA8D25CQ36353238-085F0B55-1F79-4F6A-9E12-7E49627C2B07Q36405142-74151870-1161-4547-90A5-C6A491254273Q36867266-C21589A4-C48C-4DB9-AB6D-AFCBE60B79CFQ37151611-94184D15-BCEC-4F7A-B47F-8877AAF092F0Q37326175-C3FED574-0714-40A6-9617-BEECBC1FF621Q37368611-E5F62AE5-5C10-447E-8115-8165A5A9A41BQ37371949-07FC41C9-5842-462B-89BA-1963E49C34F7Q37375378-611F35A8-2D96-44F0-840A-BB30BBB60FAEQ40985692-DB02004A-08A2-4D17-9245-8053A349001FQ41056267-3F54F8B7-7347-4D6D-8259-54592EC21E12Q41938614-338D238D-A908-4198-8B8A-2AFC96131FFDQ43248011-40F50FBA-30D2-4158-B065-47800F69BC04Q43281027-548B090E-FECC-4630-8F53-602D92133694Q43763336-87079F3D-1B66-4C7F-AE35-B1AE76BB6EDAQ44904233-51D50AF6-1B23-43CB-87DF-3CE4651735A8Q45275694-F8045B9A-754F-4FBC-A21D-47A4E3F19C18Q46634203-8CEFA657-B912-43BE-BF9F-38EB24A5004AQ55271665-D83B661B-2906-40B8-8391-6FD722BAE492
P2860
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@ast
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@en
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@nl
type
label
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@ast
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@en
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@nl
prefLabel
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@ast
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@en
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@nl
P2093
P2860
P356
P1476
Inhibition of hypercholesterol ...... esistance of LDL to oxidation?
@en
P2093
D Steinberg
E W Raines
M Sasahara
P2860
P304
P356
10.1172/JCI117301
P407
P577
1994-07-01T00:00:00Z